Evidence map›Paper›PMID 21812486›Full record

ArticleJournal of the American Chemical Society2011

Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan.

Kai-For Mo, Tao Fang, Stephanie H Stalnaker, Pamela S Kirby, Mian Liu, Lance Wells, Michael Pierce, David H Live, Geert-Jan Boons

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Chemoenzymatic Assembly of Mammalian O-Mannose Glycans.Angewandte Chemie (International ed. in English) · 2018
    Article
  5. Article
  6. Article
  7. ProteinThe Journal of biological chemistry · 2017
    Article
  8. Mechanism of Glycosylation of Anomeric Sulfonium Ions.Journal of the American Chemical Society · 2016
    Article
  9. Article
  10. Chemoenzymatic synthesis of α-dystroglycan core M1 O-mannose glycans.Chemical communications (Cambridge, England) · 2015
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. O-Mannosylation and human disease.Cellular and molecular life sciences : CMLS · 2013
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kai-For MoComplex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, Georgia 30602, USA.
Tao Fang
Stephanie H Stalnaker
Pamela S Kirby
Mian Liu
Lance Wells
Michael Pierce
David H Live
Geert-Jan Boons
University of Georgia · US

Funding

ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR005351 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI MOREMEN, KELLEY W. · 1989 to 2011
$18.4M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI LIVE, DAVID H · 2012 to 2019
$14.5M
ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR018502 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI PIERCE, J. MICHAEL · 2003 to 2011
$13.1M
Novel chemoenzymatic approaches for the synthesis of complex glycansR01GM090269 · NIGMS · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN · 2009 to 2016
$1.8M
Post-Translation Processing of Alpha-DystroglycanR21AR056055 · NIAMS · UNIVERSITY OF GEORGIA · PI LIVE, DAVID H · 2008 to 2009
$357k
NCRR NIH HHS P41 RR005351NCRR NIH HHS P41RR005351NCRR NIH HHS P41 RR018502NCRR NIH HHS P41RR018502NIAMS NIH HHS R21 AR056055NIAMS NIH HHS R21AR056055NIGMS NIH HHS P41 GM103390NIGMS NIH HHS R01 GM090269NIGMS NIH HHS R01GM090269
6 · The paper itself

Abstract

Aberrant glycosylation of α-dystroglycan (α-DG) results in loss of interactions with the extracellular matrix and is central to the pathogenesis of several disorders. To examine protein glycosylation of α-DG, a facile synthetic approach has been developed for the preparation of unusual phosphorylated O-mannosyl glycopeptides derived from α-DG by a strategy in which properly protected phospho-mannosides are coupled with a Fmoc protected threonine derivative, followed by the use of the resulting derivatives in automated solid-phase glycopeptide synthesis using hyper-acid-sensitive Sieber amide resin. Synthetic efforts also provided a reduced phospho-trisaccharide, and the NMR data of this derivative confirmed the proper structural assignment of the unusual phospho-glycan structure. The glycopeptides made it possible to explore factors that regulate the elaboration of critical glycans. It was established that a glycopeptide having a 6-phospho-O-mannosyl residue is not an acceptor for action by the enzyme POMGnT1, which attaches β(1,2)-GlcNAc to O-mannosyl moietes, whereas the unphosphorylated derivate was readily extended by the enzyme. This finding implies a specific sequence of events in determining the structural fate of the O-glycan. It has also been found that the activity of POMGnT1 is dependent on the location of the acceptor site in the context of the underlying polypeptide/glycopeptide sequence. Conformational analysis by NMR has shown that the O-mannosyl modification does not exert major conformational effect on the peptide backbone. It is, however, proposed that these residues, introduced at the early stages of glycoprotein glycosylation, have an ability to regulate the loci of subsequent O-GalNAc additions, which do exert conformational effects. The studies show that through access to discrete glycopeptide structures, it is possible to reveal complex regulation of O-glycan processing on α-DG that has significant implications both for its normal post-translational maturation, and the mechanisms of the pathologies associated with hypoglycosylated α-DG.

Indexed as

DystroglycansGlycopeptidesNuclear Magnetic Resonance, BiomolecularPhosphoproteinsPhosphorylationProtein ConformationDystroglycansGlycopeptidesPhosphoproteins

Identifiers

PMID21812486
PMCPMC3176502
OpenAlexW2080958887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.